Tag Archives: OHRP

Best High Tech Stocks To Watch For 2018

DOL Fiduciary Rule Could Be Halted Within Days of Inauguration

Bill Gross: Forget Dow 20K, Heres the Number to Watch

SEC’s Top 6 Exam Priorities for 2017

Bank of America Corp. boosted its forecast for interest income after reporting that fourth-quarter profit rose 43% on improvements in credit quality and continued cost-cutting.

Net interest income is expected to increase by about $600 million in the first quarter, Chief Financial Officer Paul Donofrio said Friday on conference call with analysts, helped by the Federal Reserve’s quarter-point rate hike in December. The Charlotte, North Carolina-based lender said revenue from interest-related products rose 6.3% to $10.3 billion in the fourth quarter.

The lender revised earnings for recent years on Oct. 4 to reflect a change in the way it accounts for certain securities held in its investment portfolio. The move brings it in line with other Wall Street firms and may reduce swings in quarterly earnings, the bank said. The firm also dissolved a business segment created in 2011 to house delinquent mortgages.

Best High Tech Stocks To Watch For 2018: Ohr Pharmaceuticals, Inc.(OHRP)

Advisors’ Opinion:

  • [By Paul Ausick]

    Ohr Pharmaceuticals Inc. (NASDAQ: OHRP) dropped more than 10% Tuesday to post a new 52-week low of $0.35 after closing at $0.39 on Monday. The stock’s 52-week high is $2.18. Volume was around 7.55 million, nearly 4 times the daily average of around 2.1 million. The company had no specific news.

  • [By William Romov]

    Last Wednesday (Dec. 6), the company received a patent for certain methods of production of its phase 2 antidepressant, AV-101.

    Penny Stock Current Share Price Dec. 4 – Dec. 8 Gain (as of Dec. 8)
    VistaGen Therapeutics Inc. (Nasdaq: VTGN) $1.80 135%
    FXCM Inc. (Nasdaq: GLBR) $1.12 124%
    Neuralstem Inc. (Nasdaq: CUR) $2.00 75.44%
    Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.49 75.29%
    ClearSign Combustion Corp. (Nasdaq: CLIR) $3.50 53.85%
    Astrotech Corp. (Nasdaq: ASTC) $4.21 51.99%
    Burcon NutraScience Corp. (Nasdaq: BUR) $0.72 44%
    LM Funding America Inc. (Nasdaq: LMFA) $3.72 42.53%
    Second Sight Medical Products Inc. (Nasdaq: EYES) $1.75 42.28%
    Globus Maritime Ltd. (Nasdaq: GLBS) $1.47 41.35%

    As a result, its share price shot up from $0.92 to $2.52 on Wednesday. The stock pulled back to $1.80 by the end of the week, for a total gain of 135% for the week.

  • [By Lisa Levin]

    Shares of OHR Pharmaceutical Inc (NASDAQ: OHRP) were down 23 percent to $1.95 after the company reported a proposed public offering of common stock and warrants.

Best High Tech Stocks To Watch For 2018: PRA Group, Inc.(PRAA)

Advisors’ Opinion:

  • [By Lee Jackson]

    PRA Group Inc. (NASDAQ: PRAA) has been hit hard recently, and shareholders may be glad to know that a director took advantage of the sell-off and stepped in to buy shares. That board member bought 143,000 shares of the financial and business services company at prices that ranged from $34.40 to $34.89. The total for the buy was set at $5 million. The stock closed Friday at $32.90, in a52-week range of $21.93 to $42.70. The consensus price target is $40.60.

Best High Tech Stocks To Watch For 2018: ConocoPhillips(COP)

Advisors’ Opinion:

  • [By Matthew DiLallo, Tyler Crowe, and Jason Hall]

    Oil prices haven’t gotten off to the fast start many expected, falling around 6% on average during the first quarter of the year. That slump came despite OPEC’s best efforts since producing nations have achieved fairly good compliance on their planned output cuts. That said, despite the lackluster oil market, we still see some interestingopportunities in the oil market. Three stocks we really like right now are DistributionNOW(NYSE:DNOW),Phillips 66(NYSE:PSX), andConocoPhillips(NYSE:COP), which all should do well in the current oil market.

  • [By Jon C. Ogg]

    Things have improved handily from a year ago in the energy sector. Still, even with a pro-energy White House, things are far from perfect in the oil and gas sector. Now ConocoPhillips (NYSE: COP) is delivering great news to its shareholders.

  • [By Matthew DiLallo]

    Oil exploration is a risky business. Not only does it cost a lot of money, but the odds of drilling a dry hole are very high. Just ask ConocoPhillips (NYSE:COP), which recorded $432 million of deepwater dry hole costs last year. It’s a problem the company is working to address by stepping away from deepwater exploration so that it can deliver steadier returns for investors.

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Salesforce.com (CRM) , Paccar (PCAR) , Cummins (CMI) , ConocoPhillips (COP) , Adobe Systems (ADBE) , Annaly Capital (NLY) and Hewlett Packard Enterprise (HPE) .

  • [By WWW.THESTREET.COM]

    ConocoPhillips (COP) was upgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: COP.

    Urban Outfitters (URBN) was downgraded to market perform at William Blair. Continued comp-store sales pressure is pushing out the timeline for a potential recovery, Blair said. 

  • [By Chris Lange]

    The number of ConocoPhillips (NYSE: COP) shares short increased to 15.87 million from the previous level of 13.22 million. Shares were trading at $44.10, within a 52-week range of $38.19 to $53.17.

Top 10 Stocks For 2019

Oracle (NASDAQ: ORCL) has been one of the long-term holds in my portfolio that I’ve anguished over, as the company continually trades sideways and at a discount to large-cap enterprise software peers Microsoft (NASDAQ: MSFT) and SAP (NYSE: SAP). The gap between Oracle and its comps has only widened since December, when the company appeared to hint at huge cloud deceleration with a weak outlook into Q3 (the period ending February for Oracle, which has a May 31 FYE). Of all the software giants, Oracle is the only one trading below 20x forward P/E, despite the massive gains in its cloud unit (which some are now questioning has veered off its hypergrowth course).

ORCL PE Ratio (Forward) data by YCharts

Top 10 Stocks For 2019: AXT Inc(AXTI)

Advisors’ Opinion:

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli

Top 10 Stocks For 2019: MannKind Corporation(MNKD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday's regular session.

  • [By Sean Williams]

    Last summer, my mind was fully set on short-selling shares (i.e., betting they go down) of drugmaker MannKind (NASDAQ:MNKD). My investment thesis was pretty straightforward: MannKind was eventually going to seek bankruptcy protection.

  • [By James E. Brumley]

    When most investors think of diabetes stocks, names like Novo Nordisk A/S (ADR) (NYSE:NVO) and MannKind Corporation (NASDAQ:MNKD) come to mind. And well they should. Novo Nordisk is the biggest insulin company in the world, and while MannKind is relatively small, it’s a name that turns heads simply because it came up with an inhalable insulin that – after a slow start – is getting a little traction.

    In both cases though, the paradigm is the same one that was first used decades ago. That is, if a person isn’t making their own insulin, then it must be introduced externally. What if instead a diabetic’s glucose levels could be controlled by turning on the cells in their body responsible for processing that sugar? That’s the approach Cell MedX Corp (OTCMKTS:CMXC) is taking, using a relatively new but very compelling science.

    While chemical-based manufactured pharmaceuticals were largely the core of healthcare for well over the past century, it’s become clear that our bodies – right down to our cells – are also electrical in nature. Not only do they produce it, they need it to function properly. The FDA has even recently approved a therapeutic device that delivers mild electrical currents to and through an individual’s body as a means of treating pain. This “electromedicine” has also shown a certain degree of efficacy as a treatment for several illnesses, including cancer. Specifically, electrical currents have been demonstrated to force pleomorphic cancer microbes into hibernation, essentially making a cancerous cell a normal, healthy cell again. So, using an electrical current as a means of therapy for diabetics isn’t far-fetched at all. Indeed, it’s quite brilliant.

    As for how Cell MedX is using the idea, it’s actually quite simple. The device is called an eBalance. At first glance it just looks like another ordinary tablet computer. A closer inspection of the e-Balance device, however, makes it clear that it’s not just another tablet. It’

  • [By Lisa Levin]

    In trading on Tuesday, healthcare shares fell 0.48 percent. Meanwhile, top losers in the sector included MannKind Corporation (NASDAQ: MNKD), down 10 percent, and BioDelivery Sciences International, Inc. (NASDAQ: BDSI) down 10 percent.

Top 10 Stocks For 2019: Nam Tai Electronics Inc.(NTE)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another stock that’s starting to move within range of triggering a big breakout trade is Nam Tai Electronics (NTE), which is an electronics manufacturing and design services provider to a select group of the world’s leading OEMs of telecommunications and consumer electronic products. This stock has been destroyed by the sellers so far in 2013, with shares off sharply by 41%.

    If you look at the chart for Nam Tai Electronics, you’ll notice that this stock has been uptrending for the last month and change, with shares moving higher from its low of $6.05 to its recent high of $8.38 a share. During that uptrend, shares of NTE have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of NTE within range of triggering a big breakout trade.

    Traders should now look for long-biased trades in NTE if it manages to break out above some key near-term overhead resistance levels at $8.38 to $8.79 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 647,483 shares. If that breakout triggers soon, then NTE will set up to re-fill some of its previous gap down zone from April that started near $11.50 a share. If this stock gets into that gap with volume, then the upside is tremendous and we could easily see NTE hit $11 to $12 a share.

    Traders can look to buy NTE off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $7.42 a share, or below more key support at $7.22 a share. One can also buy NTE off strength once it takes out that breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 10 Stocks For 2019: Ohr Pharmaceuticals, Inc.(OHRP)

Advisors’ Opinion:

  • [By Lisa Levin]

    OHR Pharmaceutical Inc (NASDAQ: OHRP) was down, falling around 14 percent to $0.663. Ohr Pharma reported an offering common stock & warrants.

    Commodities

  • [By Paul Ausick]

    Ohr Pharmaceuticals Inc. (NASDAQ: OHRP) dropped nearly 83% Friday to post a new 52-week low of $0.35 after closing at $2.02 on Thursday. The stock’s 52-week hig is $2.18. Volume was around 32.6 million, more than 30 times the daily average of around 1.2 million. The company reported that topline data from a clinical study failed to meet its primary endpoint.

  • [By Paul Ausick]

    Ohr Pharmaceuticals Inc. (NASDAQ: OHRP) dropped more than 10% Tuesday to post a new 52-week low of $0.35 after closing at $0.39 on Monday. The stock’s 52-week high is $2.18. Volume was around 7.55 million, nearly 4 times the daily average of around 2.1 million. The company had no specific news.

  • [By Paul Ausick]

    Ohr Pharmaceuticals Inc. (NASDAQ: OHRP) traded down about 3% Wednesday and posted a new 52-week low of $0.31 after closing Tuesday at $0.32. The 52-week high is $2.18. Volume was over 10 million, more than 4 times the daily average of around 2.4 million shares. The company had no specific news.

  • [By William Romov]

    Before we show you our pick, here are the top 10 penny stocks to watch this week

    Penny Stock Current Share Price Nov. 27-Dec. 1 Gain (as of Dec. 1)
    Pyxis Tankers Inc. (Nasdaq: PXS) $4.10 122.83%
    Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.28 68.42%
    Cerecor Inc. (Nasdaq: CERC) $1.74 47.46%
    Proteostasis Therapeutics Inc. (Nasdaq: PTI) $2.52 37.71%
    UT Starcom Holdings Corp. (Nasdaq: UTSI) $5.20 37.20%
    WMIH Corp. (Nasdaq: WMIH) $0.96 33.46%
    PhaseRx Inc. (Nasdaq: PZRX) $0.90 30.29%
    Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $2.04 29.94%
    EV Energy Partners LP (Nasdaq: EVEP) $0.86 27.76%
    Catalyst Pharmaceuticals Inc. (Nasdaq: CPRX) $4.40 25.71%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, its completely free

Top 10 Stocks For 2019: Aerohive Networks, Inc.(HIVE)

Advisors’ Opinion:

  • [By Monica Gerson]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Citigroup Inc (NYSE: C) to report quarterly earnings at $1.16 per share on revenue of $17.34 billion before the opening bell. Citigroup shares rose 0.47 percent to $48.70 in after-hours trading.
    HP Inc (NYSE: HPQ) disclosed that it would be implementing a restructuring plan that would likely result in the firing of 3,000 to 4,000 employees, annual savings of $200 million to $300 million, and a charge of $350 million to $500 million. Management also announced a 7 percent surge in the stock’s dividend and an additional $3 million share repurchase program. The company issued its outlook for fiscal 2017, guiding for EPS of $1.55 to $1.65, mostly below the Street’s consensus of $1.64. HP shares fell 1.32 percent to $14.95 in the after-hours trading session.
    Analysts are expecting JPMorgan Chase & Co. (NYSE: JPM) to have earned $1.39 per share on revenue of $23.99 billion in the latest quarter. JPMorgan will release earnings before the markets open. JPMorgan shares gained 0.37 perecent to $67.99 in after-hours trading.
    Aerohive Networks Inc (NYSE: HIVE) reported weak preliminary results for its third quarter. The company said it expects a net loss of $(0.06) to $(0.07) per share, versus consensus at $(0.04) per share. Revenue guidance of $40 million also fell short of expectations for almost $48 million. Aerohive shares dropped 18.29 percent to $4.60 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin]

    Shares of Aerohive Networks Inc (NYSE: HIVE) were down 33 percent to $3.10. Aerohive Networks reported a Q2 loss of $3.9 million on revenue of $42.3 million, and disclosed that it has extended its $10 million buyback plan.

Top 10 Stocks For 2019: Tallgrass Energy Partners, LP(TEP)

Advisors’ Opinion:

  • [By Garrett Cook]

    Citi remains Buy rated on Dominion Midstream Partners (NYSE: DM), Tallgrass Energy (NYSE: TEP), and Tallgrass Energy GP (NYSE: TEGP), saying the companies are positioned to capitalize on natural gas demand growth.

Top 10 Stocks For 2019: Navios Maritime Holdings Inc.(NM)

Advisors’ Opinion:

  • [By Nickey Friedman]

    Navios Maritime Holdings (NYSE: NM  ) has two operating segments: shipping and logistics. Analysts have already begun to raise their profit estimates for 2014, currently at $0.11 EPS up from $0.01 a week ago. Expect that number to continue to rise dramatically. Navios pays a $0.06 per share quarterly dividend and trades around 40% below its book value. It used to trade as high as $17 back in 2007.

  • [By Monica Gerson]

    Navios Maritime Holdings Inc. (NYSE: NM) is expected to report a quarterly loss at $0.37 per share on revenue of $101.51 million.

    Pure Storage Inc (NYSE: PSTG) is estimated to post a quarterly loss at $0.23 per share on revenue of $138.13 million.

Top 10 Stocks For 2019: Bunge Limited(BG)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Bunge (BG) has dropped 1.5% to $76.14 after getting cut to Underweight from Neutral at JPMorgan.

    L Brands (LB) has jumped 3.9% to $44.80 despite reporting weaker than expected same-store sales.

  • [By Steve Symington]

    Shares ofBunge Ltd.(NYSE:BG)rose 10% on Wednesday after the agribusiness and food company released strong fourth-quarter 2016 results.

    So what

    Quarterly revenue grew 8.6% year over year, to $12.1 billion, and translated to 14.1% growth in adjusted earnings per share, to $1.70. Analysts, on average, were only expecting Bunge to report revenue of $11.4 billion and adjusted earnings of $1.57 per share.

  • [By Casey Wilson]

    Many companies provide the infrastructure needed for farmers to move crops from the farm to the grocery store. Among those are Bunge Ltd. (NYSE: BG), an agribusiness and food company that specializes in the purchase, storage, processing, and transport of agricultural goods. BG is up over 8% year to date and has grown over 1.5% in the past 30 days.

Top 10 Stocks For 2019: Maximus, Inc.(MMS)

Advisors’ Opinion:

  • [By Michael Flannelly]

    Analysts at Jefferies initiated coverage on business process services provider Maximus Inc. (MMS) late on Thursday, giving the stock a bullish rating because it has several competitive advantages and should benefit from the Affordable Care Act (Obamacare).

    The analysts rate MMS as “Buy” and see shares reaching $47. This price target suggests a 20% upside to the stock’s Thursday closing price of $39.14.

    “MMS is a leading government outsourced contractor that produces consistently strong results,” Jefferies analyst David Styblo commented. “The company has several competitive advantages and is highly focused on health and human service projects. This positions MMS to enjoy multi-year growth from the ACA and other opportunities with limited risk. The company’s predictable business model, solid balance sheet, and EPS visibility into FY2014 also support a Buy and $47 PT.”

    Maximus shares were inactive during pre-market trading on Friday. The stock is up 23.83% year-to-date.

  • [By ]

    Maximus Inc (NYSE: MMS) holds just $16 million in long-term debt against $886 million in shareholder equity. Shares trade for 1.7 times sales for a discount of 26% on the industry average of 2.3 times sales.

Top 10 Stocks For 2019: Molson Coors Brewing Company(TAP)

Advisors’ Opinion:

  • [By Seth McNew]

    It isn’t the only beer company facing hardships now, and in fact, it’s still growing faster than its largest competitors — Sam Adams parent Boston Beer (NYSE:SAM) and Molson Coors Brewing (NYSE:TAP). Boston Beer’s total sales fell 5.4% in 2016, year over year, and Molson Coors’ sales were down 2.3%.

  • [By ]

    Molson Coors Brewing (NYSE: TAP) is the leading brewer globally with 25% of the U.S. market, a 33% share in Canada and a fifth of the European market. The company acquired the remaining 50% stake in MillerCoors from SABMiller in 2016, giving it greater scale and international distribution.

  • [By Jayson Derrick]

    The Canadian beer market, much like the American beer market, is seeing a growth in craft products at the expense of established players. And one of the biggest established beer makers in Canada is Molson Coors Brewing Co (NYSE: TAP), Bereneberg’s Javier Gonzalez Lastra and Matt Reid commented in an initiation note.

Top 10 Stocks To Own For 2018

&l;p&g;&l;img class=&q;dam-image shutterstock size-large wp-image-447538888&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/447538888/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; Shutterstock

The day is finally approaching. You&s;ve been saving and investing most of your adult life for this moment, but now you&s;re not so sure you&s;re really ready to retire. It&s;s a predicament faced by many employees that we work with. While retirement readiness has many non-financial components to it, here&s;s how you can know if you&s;re financially ready to retire:

&l;strong&g;1) How much income will you need?&l;/strong&g; Don&s;t make the mistake of &q;guestimating&q; your expenses. That might be fine when you&s;re decades away, but you don&s;t want to discover that you&s;ve underestimated your income needs several months into retirement. Start by &l;a href=&q;https://secure.financialfinesse.com/go/3948&q; target=&q;_blank&q;&g;tracking&l;/a&g; your actual expenses over a few months and then make any adjustments you foresee to your lifestyle (like downsizing or relocating) to create a &l;a href=&q;https://secure.financialfinesse.com/go/3695&q; target=&q;_blank&q;&g;retirement budget&l;/a&g;. (You can use &l;a href=&q;https://www.aarp.org/retirement/the-aarp-healthcare-costs-calculator/&q; target=&q;_blank&q;&g;this calculator&l;/a&g; by AARP to estimate your health care expenses.)

Top 10 Stocks To Own For 2018: BIG YELLOW GROUP PLC (BYLOF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The Big Yellow Group (OTC:BYLOF) recognized this opportunity back in 1998 when it was founded and has ever since been working towards bringing new supply of self-storage properties to the UK market. The strategy resulted in the following performance:

Top 10 Stocks To Own For 2018: Microsoft Corporation(MSFT)

Advisors’ Opinion:

  • [By Money Morning News Team]

    Microsoft Corp. (Nasdaq: MSFT) has acquired 18 companies between 2016 and 2017, and its next target may be the innovative startup Mentorloop…

  • [By Sreekanth Anasa]

    It looks like Qualcomm may give Intel for a run for its money in the PC-Tablet market as well. A recent Wccftech postreports that “Qualcomms Snapdragon processors might make it on Windows 10 PCs claims Chinese supply chain. Sources report that manufacturers have already started on Windows 10 PCs. These will become available in the second half of this year. The report goes on to further suggest that testing on the Snapdragon 820 for Windows 10 with 4GB RAM is able to run Edge, HD video, directional filters and background multi-tasking.” We all know Qualcomm had a tie up recently with Microsoft (NASDAQ:MSFT) to develop Windows 10 based PCs on ARM chips. Though the above reports are speculations but the things seem to be in line with Qualcomm’s plans for diversification with sluggish smartphone sales worldwide.

  • [By Lee Jackson]

    This top old-school technology stock has posted all-time highs this year and has a massive $121.79 billion sitting on the balance sheet.Microsoft Inc. (NASDAQ: MSFT) continues to find an increasing amount of support from portfolio managers, who have added the software giant to their holdings at an increasingly faster pace all of this year and last.

  • [By JJ Kinahan]

    This week is packed full of earnings releases. A lot of eyes will be on Thursday when tech giants Microsoft Corporation (NASDAQ: MSFT), Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL), Amazon.com, Inc. (NASDAQ: AMZN) and Intel Corporation (NASDAQ: INTC) report after the market closes. The European Central Bank is also meeting that same day, potentially adding some more volatility to the mix. Next week, tech giant Apple Inc. (NASDAQ: AAPL) will open the books after market close on Thursday, Nov. 2. If you have time, make sure to check out today’s market update to see what else is happening.

  • [By Douglas A. McIntyre]

    By Douglas A. McIntyre

    « Intel’s Place in a Changing AMD and NVIDIA World 13 Cars That Compete with the Tesla Model 3 »
    Read more: Investing, Salesforce.com (NYSE:CRM), Walt Disney (NYSE:DIS), GOOGL, Microsoft (NASDAQ:MSFT), Twitter, Inc. (NYSE:TWTR)

    Free Daily Newsletter
    Subscribe

    Terms & Conditions

    Popular 10 Disappearing Car BrandsCustomer Service Hall of ShameThe Best and Worst Run States in America: A Survey of All 5026 National Monuments President Trump Wants to Shut DownCompanies Stashing the Most Money Overseas Recent A

Top 10 Stocks To Own For 2018: Ohr Pharmaceuticals, Inc.(OHRP)

Advisors’ Opinion:

  • [By Lisa Levin]

    OHR Pharmaceutical Inc (NASDAQ: OHRP) was down, falling around 14 percent to $0.663. Ohr Pharma reported an offering common stock & warrants.

    Commodities

  • [By Lisa Levin]

    Shares of OHR Pharmaceutical Inc (NASDAQ: OHRP) were down 23 percent to $1.95 after the company reported a proposed public offering of common stock and warrants.

  • [By Paul Ausick]

    Ohr Pharmaceuticals Inc. (NASDAQ: OHRP) dropped more than 10% Tuesday to post a new 52-week low of $0.35 after closing at $0.39 on Monday. The stock’s 52-week high is $2.18. Volume was around 7.55 million, nearly 4 times the daily average of around 2.1 million. The company had no specific news.

  • [By Paul Ausick]

    Ohr Pharmaceuticals Inc. (NASDAQ: OHRP) dropped more than 11% Thursday to post a new 52-week low of $0.31 after closing at $0.35 on Wednesday. The stock’s 52-week high is $2.18. Volume was around 5.5 million, more than double the daily average of around 2.3 million. The company had no specific news.

Top 10 Stocks To Own For 2018: CytRx Corporation(CYTR)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another under-$10 biotechnology player that’s starting to trend within range of triggering a major breakout trade is CytRx (CYTR), which has an oncology pipeline that includes two programs in clinical development for cancer indications: aldoxorubicin and tamibarotene. This stock has been moving to the upside during the last three months, with shares up by 21%.

    If you take a look at the chart for CytRx, you’ll notice that this stock has been trending sideways inside of a consolidation chart pattern for the last two months, with shares moving between $2.27 on the downside and $2.68 on the upside. That consolidation pattern has occurred right above this stock’s 50-day and 200-day moving averages. Shares of CYTR have now started to break out above some near-term overhead resistance at $2.49 a share. That move is quickly pushing CYTR within range of triggering an even bigger breakout trade above the upper-end of its recent sideways trading chart pattern.

    Market players should now look for long-biased trades in CYTR if it manages to break out above some near-term overhead resistance levels at $2.68 to $2.80 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 154,838 shares. If that breakout triggers soon, then CYTR will set up to re-test or possibly take out its next major overhead resistance levels at $3.20 to $4 a share.

    Traders can look to buy CYTR off any weakness to anticipate that breakout and simply use a stop that sits right below its 200-day at $2.33 a share or below more support at $2.27 a share. One can also buy CYTR off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 10 Stocks To Own For 2018: ONEOK Inc.(OKE)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Energy infrastructure companies ONEOK (NYSE:OKE) and TransCanada (NYSE:TRP) are both emerging from the energy market downturn as stronger entities. Each made smart acquisitions, with TransCanada buying U.S. gas pipeline company Columbia Pipeline Group, while ONEOK is in the process of gobbling up its MLP,ONEOK Partners (NYSE:OKS). While these deals enhanced the growth profiles of both companies, TransCanada still stands out as the better buy for long-term income investors. Here’s why.

  • [By Garrett Cook]

    Citi maintains Buy ratings on Targa Resources (NYSE: TRGP), ONEOK (NYSE: OKE) and Oneok Partners (NYSE: OKS) citing the companies stories around natural gas liquids (NGLs).

Top 10 Stocks To Own For 2018: Papa Murphy's Holdings, Inc.(FRSH)

Advisors’ Opinion:

  • [By Peter Graham]

    The Q4 earnings report forsmall cap Take ‘N’ Bake pizza chain stock Papa Murphy’s Holdings (NASDAQ: FRSH) is scheduled for after the market closes on Wednesday (March 15th). In February, our Under the Radar Moversnewsletter suggested shorting the stock by saying:

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggested shorting small cap Take ‘N’ Bake pizza chain stock Papa Murphy’s Holdings (NASDAQ: FRSH):

Top 10 Stocks To Own For 2018: AquaVenture Holdings Limited (WAAS)

Advisors’ Opinion:

  • [By Jim Robertson]

    There were six IPOs scheduled for this week (five yesterday and one today) with small cap Aquaventure Holdings LLC (NYSE: WAAS) appearing set to end the week with shares above their IPO debut price. AquaVenture Holdings is a global leader in water purification solutions and a pioneer in providing Water-as-a-Service (WAAS), generating recurring revenue from the deployment of advanced water filtration, sanitization, purification and desalination technologies. Through its subsidiaries,the Companyserves over 40,000 customers and delivers seven billion gallons of clean water each year.

Top 10 Stocks To Own For 2018: First Capital Bancorp Inc.(VA)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows JetBlue Airways Corporation giving a good performance thats still not as good as that of large cap Southwest Airlines Co (NYSE: LUV) while the performance ofAlaska Air Group, Inc (NYSE: ALK), which has acquired Virgin America Inc (NASDAQ: VA), seems to have slipped recently:

Top 10 Stocks To Own For 2018: China HGS Real Estate, Inc.(HGSH)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    But before we show you our pick, here are the top 10 penny stocks to watch this week…

    Penny Stocks Current Share Price (as of Jan. 5) Jan. 2-5 Gain (as of Jan. 5)
    My Size Inc. (Nasdaq: MYSZ) $1.66 152.28%
    Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.47 89.52%
    DelMar Pharmaceuticals Inc. (Nasdaq: DMPI) $1.675 58.02%
    CAS Medical Systems Inc. (Nasdaq: CASM) $1.09 55.71%
    China HGS Real Estate Inc. (Nasdaq: HGSH) $1.83 47.58%
    Aethlon Medical Inc. (Nasdaq: AEMD) $1.56 43.12%
    Midatech Pharma Plc. (Nasdaq: MTP) $1.23 43.01%
    Comstock Holding Cos. Inc. (Nasdaq: CHCI) $1.87 36.5%
    Cenveo Inc. (Nasdaq: CVO) $1.20 31.82%
    EV Energy Partners LP (Nasdaq: EVEP) $0.6844 31.62%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

Top 10 Stocks To Own For 2018: Sealed Air Corporation(SEE)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Morgan Stanley downgraded Chipotle (NYSE: CMG) to Equal-Weight.
    UBS downgraded AMC Networks (NASDAQ: AMCX) to Sell.
    Citi upgraded Sealed Air (NYSE: SEE) to Buy.
    Goldman Sachs upgraded Reinsurance Group (NYSE: RGA) to Buy.

  • [By Ben Levisohn]

    Sealed Air(SEE) has fallen 0.7% to $28.35 after the food-safety company was downgraded to Equal Weight from Overweight atBarclays.

    Towers Watson(TW) has dropped 0.5% to $102.49 after it was cut to Neutral from Overweight at JPMorgan. It was also upgraded to Buy from Hold at Deutsche Bank.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was Sealed Air Corp. (NYSE: SEE) which traded down about 9% at $42.33. The stocks 52-week range is $42.01 to $50.62. Volume was nearly 11 million versus the daily average of 2.1 million shares.

stock market graph

At a time when many traditional retailers have struggled, discount chains have done well. That may be why investors punished Fred’s Inc. (NASDAQ:FRED) after the company released disappointing February sales numbers.

Image source: YCharts.

What happened

Fred’s, which owns and operates 643 discount general merchandise stores and three specialty pharmacy-only locations in the southeastern United States, reported on March 3 that overall sales for February dropped 3.5%, while comparable-store sales fell by 4%, after gaining 0.8% in the same month in the prior year.

In addition to having a rough sales month, Fred’s is still in limbo when it comes to possibly buying 865 stores from Walgreens Boots Alliance, Inc. (NASDAQ: WBA) and Rite Aid Corporation (NYSE: RAD) for $950 million in cash. That deal would more than double the size of the company, which essentially makes any past sales trends irrelevant.

stock market graph: Alexion Pharmaceuticals, Inc.(ALXN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Alexion Pharmaceuticals (ALXN) soared to the top of the S&P 500 today after its audit committee found no need to restate the company’s financials.

    Agence France-Presse/Getty Images

    Alexion Pharmaceuticalsgained 9.5% to $139.18 today, while the S&P 500 dipped 0.1% to 2,269.00.

    Morgan Stanley’sMatthew Harrison and team argue that the audit committees report is “lifting a cloud” over Alexion, but they still have their concerns:

    Without significant fireworks mgt. has filed the 10-Q lifting a cloud around the details on the potential wrong doing and its impact. While the “pull-in” sales had less than a 1% impact and do not appear pervasive in use as evidenced by the limited amount outside of 4Q15, we do wonder how the increased scrutiny will impact the selling organization and the potential increased conservatism among personnel going forward. We look forward to 2017 guidance and updates to MG filing and 1210 enrollment at the 4Q16 call.

    Alexion’s market capitalization rose to $31.2 billion today from $28.5 billion yesterday. It reported net income of $144 million on sales of $2.5 billion in 2015.

  • [By Ben Levisohn]

    Alexion Pharmaceuticals (ALXN) jumped to the top of the S&P 500 today after Barclays upgraded the biotech stock to Overweight from Equal Weight citing fewer macro headwinds.

    Getty Images

    Shares of Alexion Pharmaceuticals gained 5.2% to $125.59, while the S&P 500 rose 0.1%.

    Barclays analyst Geoff Meacham and team explain why they upgraded Alexion Pharmaceuticals:

    We are upgrading shares ofAlexion to Overweight and increasing our PT to $155 from $150 on an improved outlook for 2017. Specifically, we see lower FX and fewer macroeconomic risks to the core base business over the next 12 months. We also expect approval of Soliris in refractory gMG by YE17 following a planned regulatory submission in 1Q17, which could add another growth lever in early 2018 at the latest. Our upgrade is not a call on the recent 10-Q delay, which according to our discussions with management has to do with an investigation into sales practices following allegations by a former employee. We also do not anticipate major restatements of historical Soliris sales due to the investigation. Furthermore, this is not a call on Kanuma or the Synageva deal, as we have cut our Kanuma sales in our P&L and reduced its contribution in our NPV valuation. Indeed, we would expect minimal weakness inAlexion shares if the company were to take a write-down on Synageva during 2017, but this is not core to our investment thesis. In sum, our bullishness onAlexion shares is due to: 1) lessened FX and macroeconomic headwinds in 2017, 2) near-term Soliris growth from likely regulatory approval in refractory gMG, and 3) attractive upside potential from current levels as the pipeline including line extensions for Soliris and new assets such as 1210 mature.

    Alexion Pharmaceuticals’ market capitalization rose to $28.2 billion today from $26.8 billion yesterday. It reported net income of $144 million on sales of $2.5 billion in 2015.

  • [By David Sterman]

    Growth-oriented investors should also check out Alexion Pharmaceuticals (Nasdaq: ALXN(link is external)), which falls through the cracks between the massive well-established biotechs, and the small-cap biotechs that are still pre-revenue.

    Alexion targets rare and severe diseases, and has built a broad platform of drugs to treat them. Sales growth has never been less than 37% at any point in the past eight years, and 20% to 25% growth appears locked in over coming years as well. Analysts at UBS, who see 30% upside to their $202 price target, believe that a healthy drug pipeline provides multiple catalysts this year in the form of clinical trial updates. They suggest that shares would be worth $230 in a buyout scenario. 

stock market graph: Starwood Hotels & Resorts Worldwide, Inc.(HOT)

Advisors’ Opinion:

  • [By Cameron Saucier]

    After the deal was announced, the stocks of several companies benefited from their current exposure to Cuba or newly announced ties with the island country. For example, Royal Caribbean Cruises (NYSE: RCL) jumped from $69.11 per share on July 1 to $72.99 on July 12. And Starwood Hotels & Resorts Worldwide Inc. (NYSE: HOT) hit its 52-week high of $84.37 in March after it announced new hotel deals in Cuba.

  • [By Lisa Levin]

    On Monday, cyclical consumer goods & services shares gained by 0.41 percent. Top gainers in the sector included Kandi Technologies Group Inc (NASDAQ: KNDI), Starwood Hotels & Resorts Worldwide Inc (NYSE: HOT), and Lifetime Brands Inc (NASDAQ: LCUT).

stock market graph: Ohr Pharmaceuticals, Inc.(OHRP)

Advisors’ Opinion:

  • [By William Romov]

    Before we show you our pick, here are the top 10 penny stocks to watch this week

    Penny Stock Current Share Price Nov. 27-Dec. 1 Gain (as of Dec. 1)
    Pyxis Tankers Inc. (Nasdaq: PXS) $4.10 122.83%
    Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.28 68.42%
    Cerecor Inc. (Nasdaq: CERC) $1.74 47.46%
    Proteostasis Therapeutics Inc. (Nasdaq: PTI) $2.52 37.71%
    UT Starcom Holdings Corp. (Nasdaq: UTSI) $5.20 37.20%
    WMIH Corp. (Nasdaq: WMIH) $0.96 33.46%
    PhaseRx Inc. (Nasdaq: PZRX) $0.90 30.29%
    Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $2.04 29.94%
    EV Energy Partners LP (Nasdaq: EVEP) $0.86 27.76%
    Catalyst Pharmaceuticals Inc. (Nasdaq: CPRX) $4.40 25.71%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, its completely free

  • [By William Romov]

    Last Wednesday (Dec. 6), the company received a patent for certain methods of production of its phase 2 antidepressant, AV-101.

    Penny Stock Current Share Price Dec. 4 – Dec. 8 Gain (as of Dec. 8)
    VistaGen Therapeutics Inc. (Nasdaq: VTGN) $1.80 135%
    FXCM Inc. (Nasdaq: GLBR) $1.12 124%
    Neuralstem Inc. (Nasdaq: CUR) $2.00 75.44%
    Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.49 75.29%
    ClearSign Combustion Corp. (Nasdaq: CLIR) $3.50 53.85%
    Astrotech Corp. (Nasdaq: ASTC) $4.21 51.99%
    Burcon NutraScience Corp. (Nasdaq: BUR) $0.72 44%
    LM Funding America Inc. (Nasdaq: LMFA) $3.72 42.53%
    Second Sight Medical Products Inc. (Nasdaq: EYES) $1.75 42.28%
    Globus Maritime Ltd. (Nasdaq: GLBS) $1.47 41.35%

    As a result, its share price shot up from $0.92 to $2.52 on Wednesday. The stock pulled back to $1.80 by the end of the week, for a total gain of 135% for the week.

  • [By Lisa Levin]

    Shares of OHR Pharmaceutical Inc (NASDAQ: OHRP) were down 23 percent to $1.95 after the company reported a proposed public offering of common stock and warrants.

  • [By Lisa Levin]

    OHR Pharmaceutical Inc (NASDAQ: OHRP) was down, falling around 14 percent to $0.663. Ohr Pharma reported an offering common stock & warrants.

    Commodities

stock market graph: Potash Corporation of Saskatchewan Inc.(POT)

Advisors’ Opinion:

  • [By Ben Levisohn]

    We also want to reiterate our bullish view on the agricultural commodities and the ag-related stocks (e.g., CF Industries Holdings (CF), Mosaic (MOS), Potash Corp. of Saskatchewan (POT), FMC (FMC), AGCO, Deere). Following sharp multi-year declines, trends continue to improve.

  • [By Shanthi Rexaline]

    Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers

    Monsanto Company (NYSE: MON): +68.82 percent since 2011. Syngenta AG (ADR) (NYSE: SYT): +56.26 percent since 2011. Mosaic Co (NYSE: MOS): -63.1 percent since 2011. Potash Corporation of Saskatchewan (USA) (NYSE: POT): -67.8 percent since 2011. CF Industries Holdings, Inc. (NYSE: CF): +5.04 percent since 2011. Agrium Inc. (USA) (NYSE: AGU): +1.10 percent since 2011.

    Agri-Finance Companies

stock market graph: Prestige Brand Holdings Inc.(PBH)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Castor believes the cash has disappeared into working capital, which has grown from 23% to more than 50% since 2008. Comparable company PrestigeBrand (PBH) uses 11%; Unilever(UL) and Colgate-Palmolive(CL) far less.

stock market graph: Arcadia Biosciences, Inc.(RKDA)

Advisors’ Opinion:

  • [By Peter Graham]

    The Q3 2016 earnings report formid cap pet stock agricultural biotechnology Arcadia Biosciences (NASDAQ: RKDA) is scheduled for after the market closes onThursday (November 10th). Last Thursday, our Under the Radar Movers newsletter suggestedthe stockas a short/bearish trade, saying:

  • [By Jim Robertson]

    Yesterday, our Under the Radar Movers newsletter suggested small cap agricultural biotechnology Arcadia Biosciences (NASDAQ: RKDA) as a short/bearish trade:

online stock broker

Costco (NASDAQ:COST) continues to squander an opportunity by operating as if the internet has not become a major factor in retail.

The company has proven resilient in the face of digital competitors led by Amazon (NASDAQ:AMZN). While other retailers are shuttering stores, losing sales, and generally fighting for survival, the warehouse chain has not had that problem.

Costco had a decent fiscal 2016, with comparable-store sales up 4% globally and 3% in the United States when the impact of falling gasoline prices is factored out. In addition, net income for the year was roughly the same as 2015, coming in at $2.35 billion, or $5.33 per diluted share, compared to $2.38 billion, or $5.37 per diluted share last year.

Those numbers dropped a little in the first quarter of 2017, which covers the period ending November 20. During Q1, comparable-store sales were up just 1% for the U.S., with the total company posting a 2% gain. Net income, however, came in a bit better, with the company reporting $545 million, or $1.24 per diluted share, compared to $480 million, or $1.09 per diluted share, in Q1 of fiscal 2017.

online stock broker: Leucadia National Corporation(LUK)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Leucadia National (NYSE:LUK) is a difficult business for many investors to understand. The combination of the Jefferies Group financial services company, the National Beef meat processing and supply company, and plenty of other smaller investments present a challenge for those seeking to know the ins and outs of what affects Leucadia’s results. In general, though, conditions in the financial industry have been more volatile than the rest of the business, and Jefferies, therefore, plays a bigger role in how the overall company does.

  • [By Ben Levisohn]

    Then there were financial results released by Jefferies, a unit of Leucadia National (LUK). Its results are often seen as a harbinger for the big U.S. banks, and the results “appear mixed,” according to JMP analyst Devin Ryan. He explains:

  • [By Ben Levisohn]

    Lee offers 22 stocks that could benefit from the correlation trade: Western Digital (WDC), Xerox (XRX), First Solar, Ford Motor, Best Buy (BBY), PulteGroup (PHM), AutoNation (AN), Textron (TXT), Jacobs Engineering Group (JEC), Mosaic, BB&T (BBT), Fifth Third Bancorp (FITB),Loews (L), Regions Financial (RF), KeyCorp (KEY), Comerica (CMA), Leucadia National (LUK), Zions Bancorp (ZION), Valero Energy (VLO), Marathon Oil, Cardinal Health (CAH), and Pepco Holdings (POM).

  • [By Ben Levisohn]

    We delved into Kraft Heinz’s (KHC) earnings beat, and explained the impact of Leucadia National’s (LUK) investment in National Beef on its earnings.

  • [By Michael Hooper]

    When compared with similar companies, Berkshire Hathaway carries a premium over Markel (NYSE: MKL  ) , valued at 1.15 times book value and a 20 forward P/E ratio; and Leucadia National (NYSE: LUK  ) , valued at 1.10 times book value and a 7.16 trailing P/E.

online stock broker: Ohr Pharmaceuticals, Inc.(OHRP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of OHR Pharmaceutical Inc (NASDAQ: OHRP) were down 23 percent to $1.95 after the company reported a proposed public offering of common stock and warrants.

  • [By Lisa Levin]

    OHR Pharmaceutical Inc (NASDAQ: OHRP) was down, falling around 14 percent to $0.663. Ohr Pharma reported an offering common stock & warrants.

    Commodities

online stock broker: CTI BioPharma Corp.(CTIC)

Advisors’ Opinion:

  • [By Ashley Moore]

    Here is a list of the top 10 best small-cap stocks based on price gains per share so far in 2017:

    Company (Ticker)Price per Share% Change AquaBounty Technologies Inc. (Nasdaq: AQB)$14.338,646.99%Rennova Health Inc. (Nasdaq: RNVA)$3.133,333.73%China Gengsheng Minerals Inc. (OTCMKTS: CHGS)$0.021,718.18%Sunshine Heart Inc. (Nasdaq: SSH)$3.851,071.43%CTI BioPharma Corp. (Nasdaq: CTIC)$4.30991.76%Catalyst Biosciences Inc. (Nasdaq: CBIO)$6.22853.85%TearLab Corp. (Nasdaq: TEAR)$4.20707.85%Pulmatrix Inc. (Nasdaq: PULM)$3.86566.10%Real Goods Solar Inc. (Nasdaq: RGSE)$1.43498.75%Calithera Biosciences Inc. (Nasdaq: CALA)$11.70281.54%

online stock broker: Meredith Corporation(MDP)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    Meredith Corp. (NYSE: MDP), the publishing, database and television station owner, has been described in several media reports as the most likely buyer of Time Inc. (NYSE: TIME). However, there are reports that the talks have stalled over valuation, which many experts believe will need to be above $20 a share to get the approval of Time’s board.

  • [By Jon C. Ogg]

    Meredith Corp. (NYSE: MDP) was maintained as Hold but the price target was raised to $65 (versus a $62.75 close) at Benchmark.

    Norfolk Southern Co. (NYSE: NSC) was downgraded to Underperform from Sector Perform at RBC Capital Markets.